Hikma Pharmaceuticals sets price indication for benchmark five-yr bond

April 1, 2015 7:09 AM

4 0

DUBAI, April 1 (Reuters) - Hikma Pharmaceuticals has set initial price thoughts for a five-year dollar bond of benchmark size, which is likely to price as early as Wednesday, a document from lead arrangers showed.

The drugs group founded in Jordan in 1978 set initial price thoughts in the area of 300 basis points over midswaps.

Also read: Franklin Templeton's Zahn says overweight on Italian govt bonds

Read more

To category page